CIGMH, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal.
Expert Rev Mol Diagn. 2014 Nov;14(8):1041-52. doi: 10.1586/14737159.2014.965683. Epub 2014 Oct 15.
Gold nanoparticles have been appointed as cutting-edge platforms for combined diagnostic and therapeutic approaches due to their exquisite physicochemical and optical properties. In particular, their potential benefits in cancer settings are enormous, as they can serve as targeted vehicles for controlled drug release, photothermal therapy and gene therapy, as well as contrast imaging agents to allow for real-time monitoring of both disease and therapeutic progression. These theranostic platforms represent powerful image-guided therapeutics, tailored to maximize individual patient benefit and with the ability to significantly minimize toxic side effects. Here the authors review some of the recent advances on the development of gold nanoparticle conjugates for combined diagnostics and therapy, while reflecting on the obstacles toward translational research.
金纳米颗粒因其精致的物理化学和光学特性而被指定为用于联合诊断和治疗方法的尖端平台。特别是,它们在癌症治疗方面具有巨大的潜在益处,因为它们可以作为靶向药物载体用于控制药物释放、光热疗法和基因治疗,以及作为对比成像剂,以实时监测疾病和治疗进展。这些治疗平台代表了强大的图像引导治疗方法,旨在最大限度地提高个体患者的受益,并能够显著减少毒副作用。在这里,作者回顾了一些最近在金纳米颗粒缀合物的联合诊断和治疗开发方面的进展,同时也反思了转化研究中的障碍。